A clinical trial to find the efficacy and safety of â??Hypercumâ?? for the treatment of hypertensio

Not Applicable

Completed

• Conditions: Health Condition 1: I15- Secondary hypertension

• Registration Number: CTRI/2012/09/003020
• Lead Sponsor: MS Natural Solutions

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2013-02-14
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 16

Inclusion Criteria

•Males and females of age group 18-60 years

•Subjects who are willing to give written informed consent

•Patient running with Anti Hypertensive drugs or patient having known to be a Hypertensive patient but not yet approached any system of medication.

•Diabetic Patient or Patient running with Renal Failure or Patient having Metabolic Syndrome

•Female subjects who are confirmed as non-pregnant status and agree to comply with proper contraception throughout the study duration

•Patient is willing and able to comply with all trial requirements

Exclusion Criteria

•Severe essential hypertension

•Significant renal insufficiency [Serum Creatinine > 159 µmol/L ( > 1.8 mg/dl)]

•History of cerebro-vascular disease

•Patients with a history of HIV infection, AIDS, hepatitis B or C, or other immunosuppressive disorders

•Current diagnosis or a history of malignancy

•Drug of abuse within the past 2 years

•Pregnancy or breastfeeding

•Present history of mental diseases

•Previous participation in a clinical trial within 6 months

Study & Design

• Study Type: Interventional
• Study Design: Not specified